Anthrogen
PrivateLast Round
Seed
Nov 12, 2024
Total Funding Raised
$4M
Momentum Score
50 /100
Company Overview
Anthrogen is a bioengineering company that operates a platform to generate molecular machines for applications in human health, carbon capture, fuels, and industrials. By training large AI foundation models on protein sequences and structures, the company aims to generate novel molecular machines with atomic-level precision on demand. This technology combines genetically engineered bacteria and enzymatic cascades to convert atmospheric carbon dioxide into valuable polymers, fuels, and chemicals, offering a sustainable alternative to conventional production methods. The company, which participated in Y Combinator, was founded in 2024 by Ankit Singhal, Connor Lee, and Vignesh Karthik.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Alternative Fuels, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anthrogen Comps
Public and private peers based on sector, stage, and business model.
Anthrogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 12, 2024 |
Key People
Founding team and executive leadership
Anthrogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| Ritual Capital | Seed |
| Wayfinder Ventures | Seed |
| Regenerative Ventures Holdings | Seed |
| Wayfinder Ventures | Seed |
| Todd and Rahul's Angel Fund | Seed |
| Collaborative Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 23, 2025
Launched Odyssey, a 102B parameter model using Consensus and discrete diffusion.
- Nov 12, 2024
$4M raised in Seed round.
Anthrogen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anthrogen's valuation, stock price, and market status.
